Literature DB >> 24815498

Detection of malignant B lymphocytes by PCR clonality assay using direct lysis of cerebrospinal fluid and low volume specimens.

L Liu1, F Cao, S Wang, J Zhou, G Yang, C Wang.   

Abstract

INTRODUCTION: The diagnosis of lymphoid malignancies is often challenging in paucicellular specimens. PCR may also be limited by insufficient cells for DNA isolation and incomplete coverage of gene rearrangements. This study aims to evaluate a PCR method for IgH clonality using direct cell lysates.
METHODS: PCR amplification used cell lysate from detergent-based lysis and BIOMED-2 primers. CSF specimens were tested for 20 patients with primary CNS lymphoma or systemic lymphoma suspected for CNS involvement. Cytology and flow cytometry analysis was performed in parallel with PCR.
RESULTS: Direct lysis produced a better yield than the column-based method for DNA isolation. PCR using lysate showed an efficiency of clonality detection from a minimum of 20 tumor cells. PCR clonality was found in nine of the 20 CSFs, and positive PCR was concordant with both cytology and flow cytometry in seven cases. There were two cases positive for PCR, but indeterminate for flow cytometry because of insufficient cell events. Of the eleven PCR-negative cases, two were considered as false negative, as flow cytometry showed positive for malignant cells. The PCR was also performed successfully with a specimen from the anterior chamber of the eye.
CONCLUSION: PCR clonality with direct cell lysis of CSF is feasible, and it may overcome the limitation of DNA isolation. This PCR method may be particularly useful for small volume and low cell CSF when flow cytometry is inconclusive.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  B-cell malignancies; CNS lymphoma; CSF; PCR clonality; cell lysis

Mesh:

Substances:

Year:  2014        PMID: 24815498     DOI: 10.1111/ijlh.12255

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  6 in total

1.  Fixed nuclei as alternative template of BIOMED-2 multiplex polymerase chain reaction for immunoglobulin gene clonality testing in B-cell malignancies.

Authors:  Yuan Tang; Jie Chen; Jianchao Wang; Ke Zheng; Dianying Liao; Xiaomei Liao; Weiping Liu; Lin Wang
Journal:  Am J Blood Res       Date:  2015-12-25

2.  Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation.

Authors:  M Waterhouse; I Bartsch; H Bertz; J Duyster; J Finke
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

3.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

4.  Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.

Authors:  Adam J Olszewski; Anna D Chorzalska; Max Petersen; Thomas A Ollila; Adam Zayac; Habibe Kurt; Diana O Treaba; John L Reagan; Andrew Hsu; Pamela C Egan; James Butera; Rabin Niroula; John Vatkevich; Jordan Robison; Ilyas Sahin; Allison P Jacob; Chelsea D Mullins; Patrycja M Dubielecka
Journal:  Blood Adv       Date:  2021-12-28

5.  Effectiveness of digital PCR for MYD88L265P detection in vitreous fluid for primary central nervous system lymphoma diagnosis.

Authors:  Kun Chen; Yanchun Ma; Tianling Ding; Xinju Zhang; Bobin Chen; Ming Guan
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

6.  The value of detecting immunoglobulin gene rearrangements in the diagnosis of B-cell lymphoma.

Authors:  Can Lu; QiuYan He; Wei Zhu; ChunYan Fu; JianHua Zhou; YongGuang Tao; Shuang Liu; DeSheng Xiao
Journal:  Oncotarget       Date:  2017-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.